Patents by Inventor Thomas Francois
Thomas Francois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240143867Abstract: A helmet selection/customization process, which comprises obtaining a 3D scan of a user's head; identifying a retail helmet variant that would fit the user's head; providing the user with an option to select the identified retail helmet variant or design a custom liner for a base helmet; and in case the user selects to design a custom helmet, causing generation of a 3D model of a custom liner based on the 3D scan and a 3D model of the base helmet. The method includes determining, based on the 3D scan, parameters associated with the user's head; and accessing a database storing parameters associated with a plurality of retail helmet variants, wherein the identifying is carried out based on processing of the parameters associated with the user's head and the parameters stored in the database, so as to identify one of the variants in the plurality of retail helmet variants.Type: ApplicationFiled: March 1, 2022Publication date: May 2, 2024Inventors: CHARLES-ANTOINE DESROCHERS, JACQUES DUROCHER, THIERRY KRICK, THOMAS LEMELIN, JEAN-FRANCOIS LAPERRIERE, GUILLAUME BEAULIEU, ADAM CARLIN, MATHIEU DESJARDINS
-
Publication number: 20240096001Abstract: Provided are machine learning models that generate geometry-free neural scene representations through efficient object-centric novel-view synthesis. In particular, one example aspect of the present disclosure provides a novel framework in which an encoder model (e.g., an encoder transformer network) processes one or more RGB images (with or without pose) to produce a fully latent scene representation that can be passed to a decoder model (e.g., a decoder transformer network). Given one or more target poses, the decoder model can synthesize images in a single forward pass. In some example implementations, because transformers are used rather than convolutional or MLP networks, the encoder can learn an attention model that extracts enough 3D information about a scene from a small set of images to render novel views with correct projections, parallax, occlusions, and even semantics, without explicit geometry.Type: ApplicationFiled: November 15, 2022Publication date: March 21, 2024Inventors: Seyed Mohammad Mehdi Sajjadi, Henning Meyer, Etienne François Régis Pot, Urs Michael Bergmann, Klaus Greff, Noha Radwan, Suhani Deepak-Ranu Vora, Mario Lu¢i¢, Daniel Christopher Duckworth, Thomas Allen Funkhouser, Andrea Tagliasacchi
-
Publication number: 20230376859Abstract: A data processing system implements receiving, in a first silo, configuration parameters for performing federated training of the machine learning model using data stored in the plurality of second silos, generating a federated learning pipeline for automatically executing a plurality of tasks associated with the federated learning of the machine learning model based on the configuration parameters, causing each respective silo of the plurality of second silos to train the local instance of the machine learning model according to the federated learning pipeline, obtaining, at the first silo, the learnable parameters information associated with the local instance of the machine learning model of each silo of the plurality of second silos, and aggregating the learnable parameters information obtained from the plurality of second silos to obtain a primary instance of the machine learning model that has been fine-tuned according to the learnable parameters information.Type: ApplicationFiled: May 19, 2022Publication date: November 23, 2023Applicant: Microsoft Technology Licensing, LLCInventors: Daniel Keegan MILLER, Fuhui FANG, Thomas François René PORTET
-
Patent number: 11046694Abstract: Provided herein are antibacterial compounds represented by Formula I, or a pharmaceutically acceptable salt thereof, wherein X, Y, R4, R5, and R6 are as defined herein. Also provided are pharmaceutical compositions comprising the compounds of Formula I.Type: GrantFiled: May 8, 2018Date of Patent: June 29, 2021Assignee: Entasis Therapeutics, Inc.Inventors: Janelle Comita-Prevoir, Thomas Francois Durand-Reville, Satenig Guler, Jan Romero, Mark Sylvester, Ruben Tommasi, Camilo Velez-Vega, Xiaoyun Wu, Jing Zhang
-
Patent number: 10800778Abstract: The present invention is directed to compounds which are beta-lactamase inhibitors. The compounds and their pharmaceutically acceptable salts are useful in combination with beta-lactam antibiotics, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of R1, R2, R3, R4, R5 and R6 are described herein.Type: GrantFiled: September 15, 2017Date of Patent: October 13, 2020Assignee: Entasis Therapeutics LimitedInventors: Janelle Comita-Prevoir, Thomas Francois Durand-Reville, Lise Gauthier, John O'Donnell, Jan Romero, Ruben Tommasi, Jeroen Cunera Verheijen, Frank Wu, Xiaoyun Wu, Jing Zhang
-
Publication number: 20200165251Abstract: Provided herein are antibacterial compounds represented by Formula I, or a pharmaceutically acceptable salt thereof, wherein X, Y, R4, R5, and R6 are as defined herein. Also provided are pharmaceutical compositions comprising the compounds of Formula I.Type: ApplicationFiled: May 8, 2018Publication date: May 28, 2020Inventors: Janelle Comita-Prevoir, Thomas Francois Durand-Reville, Satenig Guler, Jan Romero, Mark Sylvester, Ruben Tommasi, Camilo Velez-Vega, Xiaoyun Wu, Jing Zhang
-
Patent number: 10376499Abstract: The present invention is directed to combinations of a ?-lactamase inhibitor with sulbactam and, optionally, imipenem/cilastatin. The combinations are useful for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant pathogens. More particularly, the invention relates to a combination of ?-lactamase inhibitor compound 1: or a pharmaceutically acceptable salt thereof, with sulbactam, or a pharmaceutically acceptable salt thereof, and, optionally, imipenem/cilastatin, or a pharmaceutically acceptable salt thereof.Type: GrantFiled: April 9, 2018Date of Patent: August 13, 2019Assignee: Entasis Therapeutics LimitedInventors: Boudewijn Lodewijk Maria DeJonge, Thomas Francois Durand-Reville, Jeroen Cunera Verheijen, Ruben Tommasi, John Mueller
-
Publication number: 20190202832Abstract: The present invention is directed to compounds which are beta-lactamase inhibitors. The compounds and their pharmaceutically acceptable salts are useful in combination with beta-lactam antibiotics, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of R1, R2, R3, R4, R5 and R6 are described herein.Type: ApplicationFiled: September 15, 2017Publication date: July 4, 2019Applicants: Entasis Therapeutics Limited, Entasis Therapeutics LimitedInventors: Gregory S. Basarab, Janelle Comita-Prevoir, Thomas Francois Durand-Reville, Lise Gauthier, Bill Moss, John O'Donnell, Jan Romero, Ruben Tommasi, Jeroen Cunera Verheijen, Frank Wu, Xiaoyun Wu, Jing Zhang
-
Patent number: 10217671Abstract: A semiconductor device comprising a switch and a method of making the same. The device, has a layout having one or more rectangular unit cells. Each unit cell includes a gate having a substantially cross-shaped part comprising four arms that divide the unit cell into quadrants; and a substantially loop-shaped part, wherein a center of the cross-shaped part is located inside the loop-shaped part, and wherein the loop-shaped part intersects each arm of the cross-shaped part to divide each quadrant into an inner region located inside the loop-shaped part; and an outer region located outside the loop-shaped part. Each unit cell also includes a substantially loop-shaped active region forming a source and drain of the switch. Each unit cell further includes a plurality of connection members extending over the gate, source and drain for providing electrical connections to the source and drain.Type: GrantFiled: January 9, 2018Date of Patent: February 26, 2019Assignee: NXP B.V.Inventors: Olivier Tesson, Thomas Francois
-
Patent number: 10217735Abstract: A semiconductor switch device and a method of making the same. The semiconductor switch device includes a field effect transistor located on a semiconductor substrate. The field effect transistor includes a plurality of gates. Each gate includes a gate electrode and gate dielectric arranged in a loop on a major surface of the substrate. The loops formed by the gates are arranged concentrically. Each gate has a source region located adjacent an inner edge or outer edge of the loop formed by that gate and a drain region located adjacent the other edge of said inner edge and said outer edge of the loop formed by that gate.Type: GrantFiled: May 16, 2017Date of Patent: February 26, 2019Assignee: NXP B.V.Inventors: Olivier Tesson, Thomas Francois
-
Publication number: 20180289681Abstract: The present invention is directed to combinations of a ?-lactamase inhibitor with sulbactam and, optionally, imipenem/cilastatin. The combinations are useful for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant pathogens. More particularly, the invention relates to a combination of ?-lactamase inhibitor compound 1: or a pharmaceutically acceptable salt thereof, with sulbactam, or a pharmaceutically acceptable salt thereof, and, optionally, imipenem/cilastatin, or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: April 9, 2018Publication date: October 11, 2018Inventors: Boudewijn Lodewijk Maria DeJonge, Thomas Francois Durand-Reville, Jeroen Cunera Verheijen, Ruben Tommasi, John Mueller
-
Publication number: 20180211882Abstract: A semiconductor device comprising a switch and a method of making the same. The device, has a layout having one or more rectangular unit cells. Each unit cell includes a gate having a substantially cross-shaped part comprising four arms that divide the unit cell into quadrants; and a substantially loop-shaped part, wherein a center of the cross-shaped part is located inside the loop-shaped part, and wherein the loop-shaped part intersects each arm of the cross-shaped part to divide each quadrant into an inner region located inside the loop-shaped part; and an outer region located outside the loop-shaped part. Each unit cell also includes a substantially loop-shaped active region forming a source and drain of the switch. Each unit cell further includes a plurality of connection members extending over the gate, source and drain for providing electrical connections to the source and drain.Type: ApplicationFiled: January 9, 2018Publication date: July 26, 2018Inventors: Olivier Tesson, Thomas Francois
-
Patent number: 9968593Abstract: The present invention is directed to combinations of a ?-lactamase inhibitor with sulbactam and, optionally, imipenem/cilastatin. The combinations are useful for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant pathogens. More particularly, the invention relates to a combination of ?-lactamase inhibitor compound 1: or a pharmaceutically acceptable salt thereof, with sulbactam, or a pharmaceutically acceptable salt thereof, and, optionally, imipenem/cilastatin, or a pharmaceutically acceptable salt thereof.Type: GrantFiled: November 17, 2015Date of Patent: May 15, 2018Assignee: Entasis Therapeutics LimitedInventors: Boudewijn Lodewijk Maria DeJonge, Thomas Francois Durand-Reville, Jeroen Cunera Verheijen, Ruben Tommasi, John Mueller
-
Publication number: 20180000800Abstract: The present invention is directed to combinations of a ?-lactamase inhibitor with sulbactam and, optionally, imipenem/cilastatin. The combinations are useful for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant pathogens. More particularly, the invention relates to a combination of ?-lactamase inhibitor compound 1: or a pharmaceutically acceptable salt thereof, with sulbactam, or a pharmaceutically acceptable salt thereof, and, optionally, imipenem/cilastatin, or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: November 17, 2015Publication date: January 4, 2018Inventors: Boudewijn Lodewijk Maria DeJonge, Thomas Francois Durand-Reville, Jeroen Cunera Verheijen, Ruben Tommasi, John Mueller
-
Publication number: 20170373054Abstract: A semiconductor switch device and a method of making the same. The semiconductor switch device includes a field effect transistor located on a semiconductor substrate. The field effect transistor includes a plurality of gates. Each gate includes a gate electrode and gate dielectric arranged in a loop on a major surface of the substrate. The loops formed by the gates are arranged concentrically. Each gate has a source region located adjacent an inner edge or outer edge of the loop formed by that gate and a drain region located adjacent the other edge of said inner edge and said outer edge of the loop formed by that gate.Type: ApplicationFiled: May 16, 2017Publication date: December 28, 2017Inventors: Olivier Tesson, Thomas Francois
-
Patent number: 9623014Abstract: The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia): or a pharmaceutically acceptable salt thereof, wherein the values of R1, R2, R3 and R4 are described herein.Type: GrantFiled: February 29, 2016Date of Patent: April 18, 2017Assignee: Entasis Therapeutics LimitedInventors: Helen Mcguire, Shanta Bist, Neil Bifulco, Liang Zhao, Ye Wu, Hoan Huynh, Hui Xiong, Janelle Comita-Prevoir, Daemian Dussault, Bolin Geng, Brendan Chen, Thomas Francois Durand-Reville, Satenig Guler
-
Publication number: 20160175290Abstract: The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia): or a pharmaceutically acceptable salt thereof, wherein the values of R1, R2, R3 and R4 are described herein.Type: ApplicationFiled: February 29, 2016Publication date: June 23, 2016Inventors: Helen Mcguire, Shanta Bist, Neil Bifulco, Liang Zhao, Ye Wu, Hoan Huynh, Hui Xiong, Janelle Comita-Prevoir, Daemian Dussault, Bolin Geng, Brendan Chen, Thomas Francois Durand-Reville, Satenig Guler
-
Patent number: 9064627Abstract: The invention proposes a radio frequency circuit which comprises a transformer with a first primary circuit, a second primary circuit, and a secondary circuit, the secondary circuit comprising an integrated first inductor, this first inductor being positioned, on an axis orthogonal to a surface of the circuit, between an integrated second and third inductor respectively comprised in the first primary circuit and second primary circuit.Type: GrantFiled: October 12, 2010Date of Patent: June 23, 2015Assignees: ST-ERICSSON SA, ST-ERICSSON (FRANCE) SASInventors: Christophe Cordier, Thomas Francois, Olivier Tesson
-
Publication number: 20120194403Abstract: The invention proposes a radio frequency circuit which comprises a transformer with a first primary circuit, a second primary circuit, and a secondary circuit, the secondary circuit comprising an integrated first inductor, this first inductor being positioned, on an axis orthogonal to a surface of the circuit, between an integrated second and third inductor respectively comprised in the first primary circuit and second primary circuit.Type: ApplicationFiled: October 12, 2010Publication date: August 2, 2012Applicants: ST-ERICSSON SA, ST-ERICSSON (FRANCE) SASInventors: Christophe Cordier, Thomas Francois, Olivier Tesson
-
Publication number: 20080111764Abstract: The assistive device (100) comprises, in a portable housing adapted for use with a single hand: at least two screens (105, 110) adapted to display images representative of messages, a selector (115, 120) for selecting at least one message displayed on one of said screens an emitter (125) for emitting sound messages and a control means (190) for controlling the emission, by said emitter, of sound signals representative of each message selected with said selector. Preferably, at least one of said screens is a touch-screen. In particular embodiments, at least one touch-screen comprises both a capacitive sensor and a resistive sensor. In particular embodiments, at least one of said touch-screens comprises a capacitive sensor comprising a conductive loop positioned under said screen. Said loop is surrounded and/or superposed on a ground plane.Type: ApplicationFiled: October 16, 2007Publication date: May 15, 2008Applicant: SMARTIO SYSTEMS SARLInventors: Thomas Francois HUGUES, Manuel Jose GONZALES